Similarly, higher TMB was associated with oligo-acquired resistance to ICI (<3 new or progressing lesions) in NSCLC patients36 suggesting that a persistently inflamed tumour microenvironment with increased number of mutations and PD-L1 expression is a common pattern in acquired resistance. The gene discussed is CD274; the disease is non-small cell lung carcinoma.